Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Jorgensen

Showing results (401-410 of 567) with videos related to

Pageof 57
Sort By:
Tetrahedron Letters|August 16, 2021
Indoloxytriazines as binding molecules for the JAK2 JH2 pseudokinase domain and its V617F variantAna S Newton, Maria-Elena Liosi, Sean P Henry, et al.
Bone Marrow Transplantation|September 13, 2016
Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomesJ E Brammer, R M Saliba, J L Jorgensen, et al.
Blood|September 24, 2008
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemiasDan Jones, Rajyalakshmi Luthra, Jorge Cortes, et al.
Journal of Medicinal Chemistry|June 28, 2002
Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulationsRobert C Rizzo, Marina Udier-Blagović, De-Ping Wang, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2014
Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductaseVidya P Kumar, Jose A Cisneros, Kathleen M Frey, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2008
Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenzMarilyn B Kroeger Smith, Lenea H Rader, Amanda M Franklin, et al.
Journal of the American Chemical Society|February 29, 2012
Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interactionDennis L Buckley, Inge Van Molle, Peter C Gareiss, et al.
Journal of Medicinal Chemistry|April 25, 2020
Selective Janus Kinase 2 (JAK2) Pseudokinase Ligands with a Diaminotriazole CoreMaria-Elena Liosi, Stefan G Krimmer, Ana S Newton, et al.
ACS Chemical Biology|January 17, 2009
Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malariaTina Dasgupta, Penchit Chitnumsub, Sumalee Kamchonwongpaisan, et al.
American Journal of Clinical Pathology|June 15, 2016
Comparison of Multiparameter Flow Cytometry Immunophenotypic Analysis and Quantitative RT-PCR for the Detection of Minimal Residual Disease of Core Binding Factor Acute Myeloid LeukemiaJuan Ouyang, Maitrayee Goswami, Jie Peng, et al.
Pageof 57

Showing results (401-410 of 567) with videos related to

Sort By:
Pageof 57
Tetrahedron Letters|August 16, 2021
Indoloxytriazines as binding molecules for the JAK2 JH2 pseudokinase domain and its V617F variantAna S Newton, Maria-Elena Liosi, Sean P Henry, et al.
Bone Marrow Transplantation|September 13, 2016
Multi-center analysis of the effect of T-cell acute lymphoblastic leukemia subtype and minimal residual disease on allogeneic stem cell transplantation outcomesJ E Brammer, R M Saliba, J L Jorgensen, et al.
Blood|September 24, 2008
BCR-ABL fusion transcript types and levels and their interaction with secondary genetic changes in determining the phenotype of Philadelphia chromosome-positive leukemiasDan Jones, Rajyalakshmi Luthra, Jorge Cortes, et al.
Journal of Medicinal Chemistry|June 28, 2002
Prediction of activity for nonnucleoside inhibitors with HIV-1 reverse transcriptase based on Monte Carlo simulationsRobert C Rizzo, Marina Udier-Blagović, De-Ping Wang, et al.
Bioorganic & Medicinal Chemistry Letters|August 16, 2014
Structural studies provide clues for analog design of specific inhibitors of Cryptosporidium hominis thymidylate synthase-dihydrofolate reductaseVidya P Kumar, Jose A Cisneros, Kathleen M Frey, et al.
Bioorganic & Medicinal Chemistry Letters|January 2, 2008
Energetic effects for observed and unobserved HIV-1 reverse transcriptase mutations of residues L100, V106, and Y181 in the presence of nevirapine and efavirenzMarilyn B Kroeger Smith, Lenea H Rader, Amanda M Franklin, et al.
Journal of the American Chemical Society|February 29, 2012
Targeting the von Hippel-Lindau E3 ubiquitin ligase using small molecules to disrupt the VHL/HIF-1α interactionDennis L Buckley, Inge Van Molle, Peter C Gareiss, et al.
Journal of Medicinal Chemistry|April 25, 2020
Selective Janus Kinase 2 (JAK2) Pseudokinase Ligands with a Diaminotriazole CoreMaria-Elena Liosi, Stefan G Krimmer, Ana S Newton, et al.
ACS Chemical Biology|January 17, 2009
Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malariaTina Dasgupta, Penchit Chitnumsub, Sumalee Kamchonwongpaisan, et al.
American Journal of Clinical Pathology|June 15, 2016
Comparison of Multiparameter Flow Cytometry Immunophenotypic Analysis and Quantitative RT-PCR for the Detection of Minimal Residual Disease of Core Binding Factor Acute Myeloid LeukemiaJuan Ouyang, Maitrayee Goswami, Jie Peng, et al.
Pageof 57